Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees.
暂无分享,去创建一个
Alexia Iasonos | Qin Zhou | R. Barakat | A. Iasonos | M. Leitao | R. Soslow | M. Hensley | N. Abu-Rustum | Robert A Soslow | Joyce N Barlin | Caryn M St Clair | Kaled M Alektiar | Martee L Hensley | Mario M Leitao | Richard R Barakat | Nadeem R Abu-Rustum | K. Alektiar | C. S. St. Clair | Qin C Zhou | J. Barlin
[1] R. Barakat,et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. , 2012, Gynecologic oncology.
[2] W. Creasman. The Current Status of Lymphadenectomy in the Management of Endometrial Cancer , 2011, Women's health.
[3] G. Schaller,et al. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. , 2012, Gynecologic oncology.
[4] R. Barakat,et al. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. , 2009, Gynecologic oncology.
[5] R. Rouzier,et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). , 2011, The Lancet. Oncology.
[6] E. Kohn,et al. A Gynecologic Oncology Group study of frequent copy number aberrations in DNA repair genes and other genomic regions in stage I serous ovarian cancers. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Parmar,et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.
[8] H. Putter,et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.
[9] B. Bundy,et al. Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.
[10] J A Blessing,et al. Surgical Staging in Endometrial Cancer: Clinical—Pathologic Findings of a Prospective Study , 1984, Obstetrics and gynecology.
[11] J. Dungan. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis , 2011 .
[12] Leo Breiman,et al. Classification and Regression Trees , 1984 .
[13] P. Koper,et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. , 2000 .
[14] T. Therneau,et al. An Introduction to Recursive Partitioning Using the RPART Routines , 2015 .
[15] S. Pecorelli. Corrigendum to “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium” , 2010 .
[16] B. Bundy,et al. Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.
[17] V. Torri,et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.
[18] M. Maiman,et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. , 2004, Gynecologic oncology.
[19] P. Koper,et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.
[20] S. Yamada. Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study , 2007 .